1996
DOI: 10.1177/106002809603000305
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of a Pharmaceutical Care Model on Diabetes Management

Abstract: Our data demonstrate the effectiveness of pharmaceutical care in the reduction of hyperglycemia associated with NIDDM in a group of urban African-American patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
221
2
5

Year Published

1999
1999
2014
2014

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 265 publications
(230 citation statements)
references
References 13 publications
2
221
2
5
Order By: Relevance
“…This is a potential area for intervention for public sector as well as association of physicians in the country. The cost of the prescriptions was higher than the earlier study conducted in Karachi (Jabar et al, 1996). The therapeutic categories of the drugs prescribed in the various disciplines is explained in and is as follows that is 2267 (14.6%) antimicrobial, 1180 (7.6%) analgesics and anti-inflammatory, 419 (2.7%) antidiabetics, 1942 (12.5%) cardiovascular or renal drugs, 1553 (10%) drugs acting on CNS, 1771 (11.4%) antihistamines etc.…”
Section: Discussioncontrasting
confidence: 51%
“…This is a potential area for intervention for public sector as well as association of physicians in the country. The cost of the prescriptions was higher than the earlier study conducted in Karachi (Jabar et al, 1996). The therapeutic categories of the drugs prescribed in the various disciplines is explained in and is as follows that is 2267 (14.6%) antimicrobial, 1180 (7.6%) analgesics and anti-inflammatory, 419 (2.7%) antidiabetics, 1942 (12.5%) cardiovascular or renal drugs, 1553 (10%) drugs acting on CNS, 1771 (11.4%) antihistamines etc.…”
Section: Discussioncontrasting
confidence: 51%
“…We analysed 18 relevant RCTs [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19], some of which had not been included in previous meta-analyses [20][21][22][23][24][25]. Why do these trials not provide a reliable answer?…”
mentioning
confidence: 99%
“…The quality of life improvement in patients with cardiac failure, diabetes, hypertension, and dyslipidemia, occurring as a consequence of Pharmaceutical Care, was demonstrated by Jaber et al (1996). Hepler (2000) has also developed a project to evaluate Pharmaceutical Care in asthmatic patients; in Europe, works showing the positive impact of Pharmaceutical Care in asthma have also been developed (Gourley et al, 1998;Hepler, 2000).…”
Section: Introductionmentioning
confidence: 99%